CXCL1 and cardiac hypertrophy: (1) Mice with UA injection upregulated CXCL1 protein levels in hearts; (2) CXCR2 antagonist preserved UA-induced cardiac hypertrophy and suppressed cardiac inflammation and fibrosis; (3) silencing of CXCR2 in human monocytes abolished UA-induced monocyte migration.